[144] Arbe Robotics Ltd. SEC Filing

Rhea-AI Filing Summary

Arbe Robotics Ltd. (ARBEW) submitted a Form 144 disclosing a proposed sale of 162,158 ordinary shares with an aggregate market value of $315,170, scheduled approximately for 09/22/2025 on NASDAQ. The securities were originally acquired in a private placement on 03/30/2016 from Arbe Robotics Ltd., totaling 4,261,734 shares at cash payment. The filing also reports recent sales by Canaan Partners Israel of 100,000 and 87,842 ordinary shares on 09/18/2025 and 09/19/2025 respectively, generating gross proceeds of $149,690.00 and $147,864.44. The filing includes the required representation that the seller is not aware of undisclosed material adverse information.

Positive

• Regulatory transparency: The Form 144 provides required disclosure of the proposed sale, including quantities, broker, and acquisition history.
• Detailed provenance: Acquisition date and method (03/30/2016 private placement) and payment method (cash) are disclosed, aiding investor clarity.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine Form 144 disclosing a modest proposed sale; no earnings or new corporate developments disclosed.

The filing documents a proposed sale of 162,158 ordinary shares (~0.15% of 105,163,188 shares outstanding) with an aggregate market value of $315,170. Acquisition details show the shares originated from a 2016 private placement. Two recent block sales by Canaan Partners Israel on 09/18/2025 and 09/19/2025 are reported with combined gross proceeds of $297,554.44. This submission is procedural and provides transparency about planned insider-related selling activity but contains no operational, financial performance, or forward-looking information that would change valuation models.

Corporate Governance Expert

TL;DR: Compliance-focused disclosure of proposed insider sale; confirms representation about absence of undisclosed material adverse information.

The filer supplies statutory details required under Rule 144 including acquisition date, nature of acquisition, broker, and recent related sales. The representation that the seller is unaware of undisclosed material adverse information is included as required. The filing does not state any corporate governance changes, executive departures, or new arrangements. From a governance perspective, this is a standard transparency filing rather than an indicator of governance action or distress.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Ordinary	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	162158	315170.00	105163188	09/22/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Ordinary	03/30/2016	Private Placement	Arbe Robotics Ltd.			4261734	03/30/2016	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Canaan Partners Israel (CPI) 47 Yehuda Hanasi St. Apt 83 Tel Aviv L3 6939109	Ordinary	09/18/2025	100000	149690.00
Canaan Partners Israel (CPI) 47 Yehuda Hanasi St. Apt 83 Tel Aviv L3 6939109	Ordinary	09/19/2025	87842	147864.44

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 for ARBEW disclose about the proposed sale?

The filing discloses a proposed sale of 162,158 ordinary shares with an aggregate market value of $315,170, to be sold approximately on 09/22/2025 on NASDAQ.

When and how were the shares being sold originally acquired?

The shares were acquired on 03/30/2016 in a private placement from Arbe Robotics Ltd., with 4,261,734 shares recorded in that acquisition and payment made in cash.

Did the filing report any recent sales of the issuer's shares by related parties?

Yes. The filing reports Canaan Partners Israel sold 100,000 shares on 09/18/2025 for $149,690.00 and 87,842 shares on 09/19/2025 for $147,864.44.

Which broker is handling the proposed sale disclosed in the Form 144?

The broker named in the filing is Raymond James & Associates located at 880 Carillon Parkway, St. Petersburg, FL; the transaction is to be executed on NASDAQ.

Does the Form 144 state any undisclosed material adverse information about ARBEW?

The filer represents, by signing the notice, that they do not know of any material adverse information about the issuer that has not been publicly disclosed.